Norethin 1/35e-28

   
Google
 
Web NewDrugInformation.com

Norethin 1/35e-28


Drug - Norethin 1/35e-28
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ethinyl Estradiol; Norethindrone
Multiple ingredients are in alphabetical order.

Strength - 0.035MG;1MG
The potency of the active ingredient(s), Ethinyl Estradiol; Norethindrone. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Norethin 1/35e-28. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071481
The FDA assigned number to Norethin 1/35e-28. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Norethin 1/35e-28. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 12, 1988
The date Norethin 1/35e-28 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Norethin 1/35e-28. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Norethin 1/35e-28 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Norethin 1/35e-28.

Norethin 1/35e-28